Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.148 (
Thy1
)
1,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The immunopotentiating activity and mechanisms of
PSAT
and scleroglucan, two beta 1-3, beta 1-6 glucan, were investigated in mice: these polysaccharides increase the chemiluminescence of peritoneal phagocytes and the serum C3 level. Augmentation of DNA synthesis of spleen cells was induced in vivo by injecting
PSAT
or scleroglucan. An additional proliferative effect of these polysaccharides was observed when spleen cells were incubated with mitogens. Moreover,
PSAT
enhances the number of
Thy1
lymphocytes and increases the ratio of lymphocytes L3T4/Lyt2 in mice infected with Toxoplasma gondii. No significant changes in immunoglobulin levels were found. These data indicate that
PSAT
and scleroglucan favorably affect the non-specific host defense and cellular immune response in mice.
...
PMID:[Immunopharmacologic study in mice of 2 beta-1, 3, beta-1, 6 polysaccharides (scleroglucan and PSAT) on the activation of macrophages and T lymphocytes]. 278 14